WorstPills.org - Search Results for rosuvastatin (CRESTOR)

An expert, independent second opinion on more than 1,800 prescription drugs, over-the-counter medications, and supplements

Search Type: drug or dietary supplement name
Search Term: rosuvastatin (CRESTOR)

Drug Profiles \| Worst Pills, Best Pills Newsletter Articles \| Additional Information from Public Citizen

Drug and Dietary Supplement Profiles

A comprehensive review of the safety and effectiveness of this drug. If the drug is not a Do Not Use product, information on adverse effects, drug interactions and how to use the medication are included.

Search results below include drug profiles where your selected drug is a secondary subject of discussion

Worst Pills, Best Pills Newsletter Articles

Search results below include Worst Pills, Best Pills Newsletter Articles where your selected drug is a secondary subject of discussion

Still No Good Evidence That Nonstatin Drugs Prevent Heart Attacks and Strokes [hide all summaries]
(February 2016)
Statins have long been a mainstay of treatment for patients with high LDL (“bad” cholesterol) and cardiovascular disease. In this article, we explain why you should avoid combining a nonstatin cholesterol-lowering dug with a statin.
Niacin Ineffective in Treating Cardiovascular Disease [hide all summaries]
(August 2013)
A new study casts serious doubt on the usefulness of long-popular niacin products to treat or prevent cardiovascular disease.
Dangerously Blind Faith in Drug Advertising and the FDA Drug-Approval Process [hide all summaries]
(November 2011)
Learn about the results of a study concerning people's faith in the validity of the FDA drug-approval process and in the agency's restrictions on drug advertising.
Drug Interactions: Warfarin (COUMADIN) [hide all summaries]
(December 2007)
This article explains how to understand the International Normalized Ratio (INR), a test applied to a sample of a patient’s blood to determine how “thin” it is when you are using the blood thinner COUMADIN (warfarin). In addition, the article lists more than 50 drugs or dietary supplements that can interact harmfully with COUMADIN to cause the blood to be too thin (abnormal bleeding) or not thin enough which could result in lessening the effect of COUMADIN in stopping blood clot formation.
Don't Get Sold By Drug Ads on TV, Says Study [hide all summaries]
(May 2007)
Not only does this study find that consumer drug ads are not educational, it also says that the ads may oversell the benefits of the drugs and could put the public health in danger. For example, of the 24 drugs included in this advertising study, seven are listed as Do Not Use in Worst Pills, Best Pills publications. You should not rely on direct-to-consumer television advertisements as a source of drug information.
A Review of Ezetimibe (ZETIA) and Ezetimibe with Simvastatin (VYTORIN) For Cholesterol Lowering [hide all summaries]
(December 2004)
We are concerned about any new drug but are particularly concerned about the use of ZETIA together with statins.
Protecting Profits: Amlodipine With Atorvastatin (CADUET) For High Blood Pressure And High Cholesterol [hide all summaries]
(August 2004)
We can think of no medical reason why you should be taking Caduet unless you are being treated satisfactorily with doses of amlodipine and atorvastatin that are available as Caduet. If you have not been tried on more effective drugs for high blood pressure such as diuretics or beta-blockers, amlodipine is a poor choice.
Aspirin and Heart Attacks: Secondary Prevention, Yes; Primary Prevention, No [hide all summaries]
(May 2004)
Aspirin is the preferred preventive treatment for those who have already had a heart attack (secondary prevention), at least for the majority of people who are not intolerant to aspirin. However, the lack of evidence of an aspirin benefit in the primary prevention of heart attack is clearly outweighed by the increased risk of bleeding from aspirin, and you should not use aspirin for the primary prevention of heart attacks.

Additional Information from Public Citizen

Search results below include Additional Information from Public Citizen where your selected drug is a secondary subject of discussion

Statement Before the Institute of Medicine Committee Assessing the U.S. Drug Safety System (HRG Publication #1759) [hide all summaries]
Testimony on the adequacy and conclusions of FDA’s pre-approval review and ongoing post-approval reviews.
Testimony before the Senate Special Committee on Aging on The Impact of Direct-to-Consumer Drug Advertising on Seniors’ Health and Health Care Costs (HRG Publication #1751) [hide all summaries]
DTC advertising is nothing less than an end-run around the doctor-patient relationship – an attempt to turn patients into the agents of pharmaceutical companies as they pressure physicians for medications they may not need.

SHOW primary search results for rosuvastatin (CRESTOR)